Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Nitroprusside Dose-Response in Pediatric Controlled Hypotension
NCT00135668Phase 2Completed
- Sponsor
- Emmes
- Start
- Aug 2005
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sodium nitroprusside in Controlled hypotension (4 arms), sponsored by Emmes. Primary endpoints: Change in Mean Arterial Pressure From Baseline at 30 minutes and Overall Summary of Tolerability/Adverse Events at 30 days. Started Aug 2005; status: completed.
02
Drugs
sodium nitroprusside
03
Conditions
Controlled hypotension
Beyond the preview
Go deeper on NCT00135668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00135668.